近红外术中分子成像可识别前列腺癌转移性淋巴结
研究先在小鼠前列腺癌PC3异种移植模型中经尾静脉注射吲哚菁绿(ICG),24小时后近红外(NIR)成像显示所有移植瘤高荧光,中位肿瘤-背景比2.85(四分位距2.64-3.90)。随后在4例术前淋巴结肿大的前列腺癌患者中开展初步人体研究,术中在体NIR成像识别4处淋巴结肿大中的3处为荧光阳性,离体背桌NIR成像识别全部4处为荧光阳性,病理均证实为淋巴结转移。
要点
- 小鼠PC3异种移植瘤经尾静脉ICG后24小时NIR成像均高荧光,中位肿瘤-背景比2.85(四分位距2.64-3.90)。
- 4例术前淋巴结肿大的前列腺癌患者中,术中在体NIR识别3/4处淋巴结肿大为荧光阳性,离体背桌NIR识别4/4处为荧光阳性。
- 全部淋巴结肿大病理证实为转移,其中2例另有额外转移淋巴结,术中在体NIR均为荧光阳性。
核心结论
- 静脉给予的ICG在小鼠模型和前列腺癌患者中均聚集于前列腺癌组织。
- 基于静脉ICG的NIR荧光可能作为辅助工具,帮助在淋巴结转移风险较高的患者行盆腔淋巴结清扫时识别阳性淋巴结。
研究设计与样本
- 研究采用PC3前列腺癌细胞系在NOD/SCID小鼠建立异种移植模型,经尾静脉注射ICG后24小时行NIR成像并计算肿瘤-背景比。
- 随后开展初步人体研究,在4例术前淋巴结肿大的前列腺癌患者中评估全身ICG后机器人盆腔淋巴结清扫中NIR成像的作用。
主要发现
- 小鼠模型中ICG定位于PC3异种移植瘤,所有移植瘤较周围组织高荧光,中位肿瘤-背景比2.85(四分位距2.64-3.90)。
- 人体研究中,术中在体NIR成像识别4处术前淋巴结肿大中的3处为荧光阳性,离体背桌NIR成像识别全部4处为荧光阳性。
- 全部淋巴结肿大经病理检查证实为淋巴结转移。
- 4例中有2例存在额外淋巴结转移,所有额外转移淋巴结在术中在体NIR成像中均为荧光阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To propose a novel method to perform indocyanine green (ICG) based near-infrared (NIR) fluorescence imaging during pelvic lymph node dissection (PLND) for prostate cancer patients with lymph node metastasis (LNM). MATERIALS AND METHODS: A prostate cancer cell line PC3 was used to establish xenograft model in NOD/SCID mice. After tumor growth, the mice were injected with ICG through the tail vein. Xenografts and surrounding tissues were imaged with NIR camera 24 hours after intravenous ICG, and tumor-to-background ratios were calculated. We then performed a pilot human study to evaluate the role of NIR imaging in robotic PLND after systemic ICG in 4 patients with prostate cancer and preoperative lymphadenopathy. RESULTS: ICG localized to PC3 xenografts in the mice and all xenografts were highly fluorescent compared with surrounding tissues, with a median tumor-to-background ratio of 2.85 (interquartile range = 2.64-3.90). In the human study, intraoperative in vivo NIR imaging identified 3 of the 4 preoperative lymphadenopathies as fluorescence-positive, and back table ex vivo NIR imaging identified all 4 lymphadenopathies as fluorescence-positive. All the lymphadenopathies were found to be LNMs by pathologic examination. Two of the four cases had additional LNMs, all of which were fluorescence-positive with intraoperative in vivo NIR imaging. CONCLUSION: Intravenously administered ICG accumulates in prostate cancers in both a murine model and human patients. NIR fluorescence based on intravenous ICG may serve as a useful tool to facilitate the identification of positive nodes during PLND in patients with higher risk of LNMs.
引用
- Xia L, Zeh R, Mizelle J, et al. Near-infrared Intraoperative Molecular Imaging Can Identify Metastatic Lymph Nodes in Prostate Cancer. Urology. 2017. PMID: 28438626. doi:10.1016/j.urology.2017.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。